How should we manage risks associated with chronic coronary syndromes?
Eur Heart J
.
2020 Jan 14;41(3):356-358.
doi: 10.1093/eurheartj/ehz739.
Authors
Udo Sechtem
1
2
,
Peter Ong
1
Affiliations
1
Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
2
Cardiologicum Stuttgart, Stuttgart, Germany.
PMID:
31620797
DOI:
10.1093/eurheartj/ehz739
No abstract available
Publication types
Editorial
Comment
MeSH terms
Platelet Aggregation Inhibitors*
Registries
Ticlopidine*
Substances
Platelet Aggregation Inhibitors
Ticlopidine